bought DNDN

[whodi]

10,000 shares at 7.75, stock has been strong today and just tested and made intra day highs.

[whodi]

stock is flying

[Jimmy K]

getting crushed after hours

[Goods]

Looks like the government's looking into Provenge. Not good.

[whodi]

no worries, stock is right where I pretty much bought it at and its all on speculation, definitely not getting crushed. If it was down in the low 6 range, I would consider it getting crushed.



Shares in Seattle-based Dendreon (NASDAQ: DNDN - News) have shot up and down all year on news about Provenge, the biotech's prostate cancer drug. The latest rise happened in late May, when the Food and Drug Administration (FDA) provided encouraging news about Provenge. Earlier in May, the stock plunged when Dendreon got some bad news when the FDA asked for more information on Provenge.

The letter from the SEC, Dendreon said, asks for information "related to the company's clinical trials for Provenge, the company's biologics license application for Provenge filed with the (FDA), and the FDA's review of Provenge and related correspondence to and from the company, from Jan. 1, 2007 through the present."

"The SEC's letter notes that the request should not be construed as any indication by the SEC or its staff that a violation of the federal securities laws has occurred nor should it be considered a reflection upon any person, entity or security," Dendreon said, adding that officials intend to "cooperate fully with the SEC."

IMO, if the news was that bad, the stock would be getting slammed in after hours, it retreated to where it was trading at today. I wish I took some profits before the close, almost did, but I will keep a tight watch on it.

[Jimmy K]

i may pick some up this week, wanna see how it moves a little more, hope it pays off for you though.